Skip to main content
DeutschDE
European Commission logo print header

New process for a programmable design of Liposome with high affinity to the targeted tissue

Ziel

Despite many advances in modern medicine, pharmaceuticals and biotech companies are still looking for an efficient way of drug delivery enabling a better treatment without side effects. Indeed there is a growing demand to develop targeted delivery systems to deliver antibiotics, growth factors, bioactive peptides, enzymes and other non-stable compounds to the site of disease.

Nowadays liposomes seem to be one of the most appropriate solutions to overcome these problems. Nevertheless, liposomes design and production are today far from being perfect in order to face to the increasing demand of efficient drug carriers. A lack of efficacy has led to the limited success of liposomes as targeted carriers. Effectively there are nowadays some difficulties to produce them in large quantities and to control the drug delivery during their design.

Wissenschaftliches Gebiet

Programm/Programme

Thema/Themen

Data not available

Aufforderung zur Vorschlagseinreichung

SME1999/1
Andere Projekte für diesen Aufruf anzeigen

Finanzierungsplan

Data not available

Koordinator

TOPTECH PHARMACEUTICALS LTD
EU-Beitrag
Keine Daten
Adresse
Max Nordau 19b/8
REHOVOT
Israel

Auf der Karte ansehen
Gesamtkosten
Keine Daten

Beteiligte (1)

Diese Seite teilen

Herunterladen

Letzte Aktualisierung: 28 August 2009

Mein Booklet

Permalink: https://cordis.europa.eu/project/id/QLK3-CT-2001-41688/de

European Union, 2024